OMNIBUS AMENDMENT AND CONSENT (MEZZ 3)Omnibus Amendment and Consent • March 1st, 2013 • Ashford Hospitality Trust Inc • Real estate investment trusts • New York
THIS OMNIBUS AMENDMENT AND CONSENT (this “Agreement”) is entered into as of this 17th day of December, 2012, by and among (i) LVS I SPE II LLC (together with its successors and assigns, “Lender”), (ii) HH MEZZ BORROWER A-3 LLC, HH MEZZ BORROWER C-3 LLC, HH MEZZ BORROWER D-3 LLC, HH MEZZ BORROWER F-3 LLC, and HH MEZZ BORROWER G-3 LLC, each a Delaware limited liability company (individually and collectively as the context may require, “Borrower”), and (iii) Ashford Hospitality Limited Partnership, a Delaware limited partnership (“Ashford Guarantor”) and PRISA III REIT Operating LP, a Delaware limited partnership (“Prudential Guarantor”; Ashford Guarantor and Prudential Guarantor, individually and/or together, as the context may require, “Guarantor”).
EXECUTION VERSION OMNIBUS AMENDMENT AND CONSENTOmnibus Amendment and Consent • May 5th, 2020 • New York
OMNIBUS AMENDMENT AND CONSENT, dated as of June 5, 2018 (this “Amendment and Consent”), to and under (a) the Credit Agreement, dated as of June 30, 2017, among DHX MEDIA LTD., a Canadian corporation (the “Borrower”), the Lenders party thereto and Royal Bank of Canada, as Swingline Lender, L/C Issuer and Administrative Agent (the Credit Agreement as amended by this Amendment and Consent, the “Amended Credit Agreement”), (b) the Security Agreement, dated as of June 30, 2017, among the Borrower, certain other Loan Parties party thereto and the Administrative Agent (the “U.S. Security Agreement”), and (c) the Canadian Security Agreement, dated as of June 30, 2017, among the Borrower, certain other Loan Parties party thereto and the Administrative Agent (the “Canadian Security Agreement” and, together with the U.S. Security Agreement, the “Security Agreements”). Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Credit Agreem
OMNIBUS AMENDMENT AND CONSENTOmnibus Amendment and Consent • December 4th, 2006 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
OMNIBUS AMENDMENT AND CONSENT EFFECTIVE AS OF November 30, 2006 (this “Omnibus Amendment and Consent”) by and among Acura Pharmaceuticals, Inc. (the “Company”), and Acura Pharmaceutical Technologies, Inc. and the following lenders (“Lenders”): Galen Partners III, L.P. (as agent for the other lenders (“Agent”) and as a lender itself), Galen Partners International, III, L.P., Galen Employee Fund III, L.P., Care Capital Offshore Investments II, LP, Care Capital Investments II, LP, Essex Woodlands Health Ventures V, L.P. (the foregoing Lenders, being the “VC Lenders”), Dennis Adams, George E. Boudreau, Michael Weisbrot, Susan Weisbrot; and the following persons with respect to Sections 5, 6, 7, and 8: John E. Heppe Jr. and Peter Steiglitz (“Additional Watson Holders”).
OMNIBUS AMENDMENT AND CONSENTOmnibus Amendment and Consent • October 20th, 2006 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
OMNIBUS AMENDMENT AND CONSENT EFFECTIVE AS OF October 20, 2006 (this “Omnibus Amendment and Consent”) by and among Acura Pharmaceuticals, Inc. (the “Company”), and Acura Pharmaceutical Technologies, Inc. and the following lenders (“Lenders”): Galen Partners III, L.P. (as agent for the other lenders (“Agent”) and as a lender itself), Galen Partners International, III, L.P., Galen Employee Fund III, L.P., Care Capital Offshore Investments II, LP, Care Capital Investments II, LP, Essex Woodlands Health Ventures V, L.P. (the foregoing Lenders, being the “VC Lenders”), Dennis Adams, George E. Boudreau, Michael Weisbrot, Susan Weisbrot; and the following persons with respect to Sections 5, 6, 7, and 8: John E. Heppe Jr. and Peter Steiglitz (“Additional Watson Holders”).
OMNIBUS AMENDMENT AND CONSENTOmnibus Amendment and Consent • September 2nd, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • New York
This Omnibus Amendment and Consent (this “Amendment”), dated as of August 16, 2005, by and between Accentia Biopharmaceuticals, Inc., a Florida corporation (the “Company”), and Laurus Master Fund, Ltd., a Cayman Islands company (the “Purchaser”), amends that certain Securities Purchase Agreement, dated as of April 29, 2005 (the “Initial Closing Date”), by and between the Company and the Purchaser (the “Securities Purchase Agreement”); that certain Registration Rights Agreement, dated as of April 29, 2005, by and between the Company and the Purchaser (the “Registration Rights Agreement”); and that certain Secured Convertible Term Note, dated as of April 29, 2005, by the Company in favor of Purchaser for the total principal amount of $5,000,000 (the “Term Note”, collectively, with the Securities Purchase Agreement, and the Registration Rights Agreement, the “Funding Documents”). Capitalized terms used but not defined herein shall have the meanings given them in the Securities Purchase Ag
OMNIBUS AMENDMENT AND CONSENTOmnibus Amendment and Consent • August 16th, 2006 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
OMNIBUS AMENDMENT AND CONSENT EFFECTIVE AS OF August 16, 2006 (this “Omnibus Amendment and Consent”) by and among Acura Pharmaceuticals, Inc. (the “Company”), and Acura Pharmaceutical Technologies, Inc. and the following lenders (“Lenders”): Galen Partners III, L.P. (as agent for the other lenders (“Agent”) and as a lender itself), Galen Partners International, III, L.P., Galen Employee Fund III, L.P., Care Capital Offshore Investments II, LP, Care Capital Investments II, LP, Essex Woodlands Health Ventures V, L.P., Dennis Adams, George E. Boudreau, Michael Weisbrot, Susan Weisbrot; and the following persons with respect to Sections 5, 6, 7, and 8: John E. Heppe Jr. and Peter Steiglitz (“Additional Watson Holders”).
OMNIBUS Amendment and ConsentOmnibus Amendment and Consent • March 17th, 2022 • Textainer Group Holdings LTD • Services-equipment rental & leasing, nec • New York
Third Amended and Restated Indenture, dated as of November 15, 2021 (as amended or supplemented from time to time as permitted hereby, including, with respect to any Series or Class, the related Supplement, the “Indenture”), between TEXTAINER MARINE CONTAINERS II LIMITED, a company incorporated and existing under the laws of Bermuda (the “Issuer”), and WILMINGTON TRUST, NATIONAL ASSOCIATION, a national banking association (“WTNA”), as Indenture Trustee (the “Indenture Trustee”).
OMNIBUS AMENDMENT AND CONSENTOmnibus Amendment and Consent • February 27th, 2019 • Tellurian Inc. /De/ • Crude petroleum & natural gas • New York
This omnibus amendment and consent (this “Agreement”) is entered into as of November 29, 2018 (the “Effective Date”), by and among TELLURIAN PRODUCTION HOLDINGS LLC, a Delaware limited liability company (“Borrower”), the Lenders (defined below) party hereto, GOLDMAN SACHS LENDING PARTNERS LLC, as the administrative agent (in such capacity, including any successors or assigns in such capacity, “Administrative Agent”), J. ARON & COMPANY LLC, as the collateral agent (in such capacity, including any successors or assigns in such capacity, “Collateral Agent”), and, for the purpose of Section 3 below only, J. ARON & COMPANY LLC, as the initial swap counterparty under the Intercreditor Agreement (the “Initial Swap Counterparty”).
OMNIBUS AMENDMENT AND CONSENTOmnibus Amendment and Consent • December 22nd, 2006 • Diamondback Energy Services, Inc. • Crude petroleum & natural gas • New York
This Omnibus Amendment and Consent (this “Agreement”) dated effective as of December 31, 2006 (the “Effective Date”) is among Diamondback Energy Services LLC, a Delaware limited liability company (the “Existing Borrower”), certain subsidiaries of the Existing Borrower (the “Guarantors”), the lenders party to the Credit Agreement described below (the “Lenders”), and Fortis Capital Corp., as administrative agent for such Lenders (in such capacity, the “Administrative Agent”) and as issuing bank (in such capacity, the “Issuing Bank”).
OMNIBUS AMENDMENT AND CONSENTOmnibus Amendment and Consent • May 24th, 2006 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
OMNIBUS AMENDMENT AND CONSENT EFFECTIVE AS OF May 24, 2006 (this “Omnibus Amendment and Consent”) by and among Acura Pharmaceuticals, Inc. (the “Company”), and Acura Pharmaceutical Technologies, Inc. and the following lenders (“Lenders”): Galen Partners III, L.P. (as agent for the other lenders (“Agent”) and as a lender itself), Galen Partners International, III, L.P., Galen Employee Fund III, L.P., Care Capital Offshore Investments II, LP, Care Capital Investments II, LP, Essex Woodlands Health Ventures V, L.P., Dennis Adams, George E. Boudreau, Michael Weisbrot, Susan Weisbrot; and the following persons with respect to Sections 5, 6, 7, and 8: John E. Heppe Jr. and Peter Steiglitz (“Additional Watson Holders”).
OMNIBUS AMENDMENT AND CONSENTOmnibus Amendment and Consent • April 2nd, 2007 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
OMNIBUS AMENDMENT AND CONSENT EFFECTIVE AS OF March 30, 2007 (this “Omnibus Amendment and Consent”) by and among Acura Pharmaceuticals, Inc. (the “Company”), and Acura Pharmaceutical Technologies, Inc. and the following lenders (“Lenders”): Galen Partners III, L.P. (as agent for the other lenders (“Agent”) and as a lender itself), Galen Partners International, III, L.P., Galen Employee Fund III, L.P., Care Capital Offshore Investments II, LP, Care Capital Investments II, LP, Essex Woodlands Health Ventures V, L.P. (the foregoing Lenders, being the “VC Lenders”), Dennis Adams, George E. Boudreau, Michael Weisbrot, Susan Weisbrot; and the following persons with respect to Sections 5, 6, 7, and 8: John E. Heppe Jr. and Peter Steiglitz (“Additional Watson Holders”).
OMNIBUS AMENDMENT AND CONSENTOmnibus Amendment and Consent • July 10th, 2007 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
OMNIBUS AMENDMENT AND CONSENT EFFECTIVE AS OF July 10, 2007 (this “Omnibus Amendment and Consent”) by and among Acura Pharmaceuticals, Inc. (the “Company”), and Acura Pharmaceutical Technologies, Inc. and the following lenders (“Lenders”): Galen Partners III, L.P. (as agent for the other lenders (“Agent”) and as a lender itself), Galen Partners International, III, L.P., Galen Employee Fund III, L.P., Care Capital Offshore Investments II, LP, Care Capital Investments II, LP, Essex Woodlands Health Ventures V, L.P. (the foregoing Lenders, being the “VC Lenders”), Dennis Adams, George E. Boudreau, Michael Weisbrot, Susan Weisbrot; and the following persons with respect to Sections 5, 6, 7, and 8: John E. Heppe Jr. and Peter Steiglitz (“Additional Watson Holders”).
OMNIBUS AMENDMENT AND CONSENTOmnibus Amendment and Consent • September 25th, 2006 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
OMNIBUS AMENDMENT AND CONSENT EFFECTIVE AS OF September 22, 2006 (this “Omnibus Amendment and Consent”) by and among Acura Pharmaceuticals, Inc. (the “Company”), and Acura Pharmaceutical Technologies, Inc. and the following lenders (“Lenders”): Galen Partners III, L.P. (as agent for the other lenders (“Agent”) and as a lender itself), Galen Partners International, III, L.P., Galen Employee Fund III, L.P., Care Capital Offshore Investments II, LP, Care Capital Investments II, LP, Essex Woodlands Health Ventures V, L.P., Dennis Adams, George E. Boudreau, Michael Weisbrot, Susan Weisbrot; and the following persons with respect to Sections 5, 6, 7, and 8: John E. Heppe Jr. and Peter Steiglitz (“Additional Watson Holders”).
OMNIBUS AMENDMENT AND CONSENTOmnibus Amendment and Consent • April 29th, 2011 • American Greetings Corp • Greeting cards • New York
